Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
42
# OF OVERLAPPING
HOLDINGS
XBI
143
HOLDINGS
30%
ALSO IN SBIO
SBIO
84
HOLDINGS
51%
ALSO IN XBI
SECTOR DRIFT (XBI minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ORUKA THERAPEUTICS INC | 1.3% | 3.5% | 1.3% |
|
TRAVERE THERAPEUTICS, INC. | 1.2% | 3.3% | 1.2% |
|
DIANTHUS THERAPEUTICS INC | 1.1% | 3.1% | 1.1% |
|
CG ONCOLOGY, INC. | 1.0% | 3.8% | 1.0% |
|
RELAY THERAPEUTICS, INC. | 0.9% | 2.6% | 0.9% |
XBI Overweight Relative to SBIO
|
MODERNA, INC. | 2.4% |
|
TWIST BIOSCIENCE CORP. | 1.9% |
|
NATERA INC | 1.8% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.6% |
|
ABBVIE INC | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.6% |
|
BIOGEN IDEC INC | 1.6% |
|
AMGEN INC | 1.6% |
|
GILEAD SCIENCES INC | 1.5% |
|
HALOZYME THERAPEUTICS INC | 1.5% |
XBI Underweight Relative to SBIO
|
VERADERMICS INC | -3.6% |
|
DEFINIUM THERAPEUTICS INC | -3.1% |
|
EDGEWISE THERAPEUTICS, INC. | -2.9% |
|
CG ONCOLOGY, INC. | -2.8% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
TRAVERE THERAPEUTICS, INC. | -2.2% |
|
TARSUS PHARMACEUTICALS, INC. | -2.1% |
|
ORUKA THERAPEUTICS INC | -2.1% |
|
DIANTHUS THERAPEUTICS INC | -2.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -1.9% |